Skip to main content
Earnings Labs
Immuneering Corporation logo

Immuneering Corporation (IMRX)

NASDAQ·Healthcare·Biotechnology

$4.23

+2.55%

Mkt Cap $155.01M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (7 analysts)

$12.00

Range $12.00$12.00

Implied Upside

+184.0%

Consensus $12.00 vs current $4.23